Tc-99m-labeled small biomolecules as potential radiopharmaceuticals for infection and inflammation imaging

Drugs of the Future

Volumn 26, Issue 4, 2001, Pages 375-382

  Edwards, D S ^a   Liu, S ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHEMOTACTIC PEPTIDE; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; THROMBOCYTE FACTOR; TUFTSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; DRUG POTENCY; ECHOGRAPHY; INFECTION; INFLAMMATION; ISOTOPE LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; REVIEW;

EID: 0034960201     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.04.858708     Document Type: Review

References (49)

1. The uptake mechanisms of inflammation- and infection-localizing agents
2. Structure and function of adhesion receptors in leukocyte trafficking
3. Radiopharmaceuticals for the study of inflammatory processes: A review
4. Infection imaging with technetium-99m-labeled chemotactic peptide analogs
5. What is the best method for imaging focal infections?
6. The choice of an appropriate agent for imaging inflammation
7. Nuclear medicine's role in infection and inflammation
8. Tc-99m-human immunoglobulin (HIG) - First results of a new agent for the localization of infection and inflammation
9. 3 and SHNH: An in vitro and animal in vivo comparison
10. Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits
11. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: Comparison with indium-111-DTPA-IgG
12. Imaging of focal sites of inflammation in rhesus monkeys with Tc-99m-labeled human polyclonal IgG
13. Clinical experience with Tc-99m-hexamethylpropyleneamineoxime for labeling leukocytes and imaging inflammation
14. Technetium-99m-HM-PAO-labeled leukocytes in detection of inflammatory lesions: Comparison with gallium-67 citrate
15. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes
16. Failure of zidovudine prophylaxis after accidental exposure to HIV-1
17. Health officials reacting to infection mishaps
18. Infection imaging using whole-body FDG-PET
19. Tc-99m-labeled small peptides as diagnostic radiopharmaceuticals
20. Radiolabeled peptides: Now and future
21. Radiopharmaceuticals for the visualization of infectious and inflammatory lessions
22. Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals
23. Recent developments of Tc-99m-labelled peptide-based radiopharmaceuticals: A review
24. Imaging infection/inflammations
25. Small peptides radiolabeled with Tc-99m
26. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection
27. Effect of "co-ligand" on the biodistribution of Tc-99m-labeled hydrazino nicotinic acid derivatized chemotactic peptides
28. A ticket to ride: Peptide radiopharmaceuticals
29. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates
30. Comparision of the infection imaging properties of a Tc-99m labeled chemotactic peptide with In-111-IgG
31. Technetium-labeled chemotactic peptides: Comparison with Indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit
32. High-affinity no-carrier-added Tc-99m-labeled chemotactic peptides for study of inflammation in vivo
33. Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation
34. RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide conjugated chemotactic peptide for infection imaging
35. Technetium-99m labeled thienylalanyl-leucyl-phenylalanyl chemotactic peptides for imaging infection
36. Imaging inflammation with Tc-99m labelled chemotactic peptides: Analogues with reduced neutropenia
37. A new Tc-99m labeled peptide inflammation imaging agent
38. Imaging a model of colitis with RP128, a Tc-99m-chelated tuftsin antagonist
39. Human dosimetty of Tc-99m-RP128, a potential inflammation imaging agent
40. 4 antagonists as potential inflammation/infection imaging agents
41. 4 antagonists modified with amino acid "east end" and technetium-99m chelators for imaging of sites of inflammation and infection
42. 4 antagonists
43. 4 antagonist which incorporates the ligand into the binding site
44. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection
45. Tc-99m P483H for imaging infection: Phase 2 multicenter trial results
46. Radiolabeled antimicrobial peptides for imaging of infections: A review
47. Imaging of bacterial infection with Tc-99m-labeled human neutrophil peptide-1
48. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations